|
Research notes
Terror’s aftermath tough on psychiatric patients
Patients under
psychiatric care on Sept. 11, 2001, were particularly distressed after the
day’s terrorist attacks on the World Trade Center and Pentagon.
The conclusion
is based on a new Brown study. The researchers surveyed 221 psychiatric
patients and 87 medical patients at outpatient facilities at Rhode Island
Hospital two to three weeks following Sept. 11. They found that 33 percent of
psychiatric patients compared to 13 percent of medical patients reported
significant symptoms (except for duration of at least one month) of
post-traumatic stress disorder (PTSD).
However, no
differences were found between the patient groups in learning about the attacks
or in personal involvement with its victims or survivors.
“We needed
data to back up the belief that psychiatric patients are more
vulnerable,” said lead investigator Laurel Franklin, research fellow in
the Department of Psychiatry and Human Behavior.
The attacks led
to speculation by mental health groups about the vulnerability of psychiatric
patients to psychological distress. Studies of people
indirectly exposed to traumatic events
have shown greater stress-related symptoms in individuals who saw themselves as
similar to the victims, saw themselves as potential victims, or viewed the
event as highly personal.
Trauma-related
symptoms may include thinking and/or dreaming about the attacks, avoiding
reminders of them, and irritability following the attacks. Overall 28 percent
of those surveyed reported experiencing such symptoms. The psychiatric patients
had a range of diagnoses, including major depression, mood disorders, non-PTSD
anxiety and other conditions.
Additional hypotheses as to why psychiatric patients may be at
increased risk to developing PTSD symptoms include deficits in coping skills,
deficits in social support, poor psychological resiliency, biological
vulnerability, or an increased willingness to report psychiatric symptoms, said
Franklin
“It is
also important to note that medical patients reported some significant psychological
reactions and significant stress symptoms,” she said. “Our
suggestion to doctors is to talk with all patients about the Sept. 11 terrorist
attacks whether or not those patients say they are experiencing distressing
symptoms. In particular be sensitive to the effect of these tragedies on psychiatric
patients.”
Franklin
presented the findings May 20 during the annual meeting of the American Psychiatric
Association. Study co-authors are Diane Young, clinical assistant professor of
psychiatry and human behavior, and Mark Zimmerman, M.D., associate professor of psychiatry and human behavior and
director of outpatient psychiatry at Rhode Island Hospital. – Scott
J. Turner
Home is where you kick the habit
A new
stop-smoking program employs the Visiting Nurses Association of Rhode Island
(VNA of RI) to counsel homebound, medically ill smokers to kick the habit.
Typically these
patients lack access to treatment or don't seek treatment on their own, said
project leader Belinda Borrelli, assistant professor of psychiatry and human
behavior.
To help patients
quit smoking and decrease health risks, the VNA-based effort provides brief,
tailored behavioral intervention in the form of support, state-of-the-art
treatment and follow-up care. Previous research has shown these methods are
practical and cost-effective.
"Underlying
these methods is the understanding that behavioral change for smokers takes a
long time and that it is typical for smokers to be ambivalent during that
period of change,” Borrelli said. "The nurses are empathetic to that
ambivalence and are trained to work with it and either help those who want to
quit or motivate those who are not ready to quit move toward that goal."
The program will
target every VNA patient who smokes, or about 600 individuals per year. The
Tobacco Control Program in the Rhode Island Department of Health funds the
project.
Borrelli is
based in the Centers for Behavioral and Preventive Medicine, Brown Medical
School/The Miriam Hospital. The project builds upon a seven-year collaboration
between the Centers and the VNA of RI. – Scott J. Turner
$500,000 grant for hepatitis research
The Medical
School recently received a five-year $500,000 grant from Bristol-Myers Squibb
to support research into the molecular role of hepatitis B virus and hepatitis
C virus in liver cancer. Jack R. Wands, M.D., will supervise and serve as
principal investigator of the grant. He studies targeted gene therapy for
treating liver cancer caused by hepatitis.
“The
prospects of having a targeted therapy for this devastating disease are
exciting and we wish Dr. Wands and his colleagues great success," said
Richard Colonno of the Bristol-Myers Squibb Pharmaceutical Research Institute.
A professor of
medical science, Wands is the Jeffrey and Kimberly Greenberg-Artemis and Martha
Joukowsky Professor in Gastroenterology. He directs the Liver Research Center
and the Division of Gastroenterology at Rhode Island Hospital and The Miriam
Hospital. – Scott J. Turner
|